EUR USD GBP
+353-1-416-8900REST OF WORLD
1-800-526-8630U.S. (TOLL FREE)

Metabolomics Market - Forecast to 2021

  • ID: 4089861
  • Report
  • March 2017
  • Region: Global
  • 297 Pages
  • Markets and Markets
1 of 4
The Global Metabolomics Market is Estimated to Reach USD 2.39 Billion by 2021, at a CAGR of 14.6%

FEATURED COMPANIES

  • Bruker Corporation
  • Danaher Corporation
  • Leco Corporation
  • Metabolon, Inc.
  • Shimadzu Corporation
  • Waters Corporation
  • MORE

The global metabolomics market is projected to reach USD 2.39 billion by 2021, at a CAGR of 14.6% during the forecast period of 2016 to 2021. The metabolomics market has witnessed significant growth primarily due to the increasing need for accurate diagnosis of diseases, rising demand for personalized medicine, and emergence of advanced technologies.

In this report, the global metabolomic market is segmented by product and service, application, indication, and region. Based on product and service, this market is further segmented into two major segments-metabolomics instruments and metabolomics bioinformatics tools & services. Based on metabolomics instruments, the market is further segmented into detection tools and separation tools. The separation tools segment commanded the largest share in the global metabolomics instruments market in 2015. The large share of this segment can be attributed to the ease of separation, characterization of metabolites, and quantitation of chemical compounds achieved by separation tools such as UPLC.

Based on application, the market is segmented into biomarker discovery, drug discovery, nutrigenomics, toxicology testing, personalized medicine, functional genomics, and others. In 2015, the biomarker discovery segment accounted for the largest share of the global metabolomics market. The personalized medicine segment is expected to register the highest CAGR during the forecast period due to collaborations between pharmaceutical companies and biotechnology firms for biomarker discovery and validation.

In 2015, North America commanded the largest share of the metabolomics market, followed by Europe. The U.S. is the prime market for metabolomics due to the rising acceptance of personalized medicines and growing focus of stakeholders on research projects involving metabolites, amino acid composition, and associated biomolecules in the country. The Asia-Pacific market is expected to witness the highest growth in the coming years primarily due to the growing focus of manufacturers on this region.

Major players in the global metabolomics market are Agilent Technologies, Inc. (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Shimadzu Corporation (Japan), Waters Corporation (U.S.) Bio-Rad Laboratories (U.S.), Biocrates Life Sciences AG (Austria), Human Metabolome Technologies Inc. (Japan), LECO Corporation (U.S.), and Metabolon Inc. (U.S.).

Research Coverage

Detailed insights on all the submarkets, based on metabolomics instruments (Gas Chromatography, Capillary Electrophoresis, High-performance Liquid Chromatography, Ultra-performance Liquid Chromatography, Nuclear Magnetic Resonance Spectroscopy, Mass Spectrometry, and Surface-based Mass Analysis), this can help market players to identify high growth segments in the metabolomics market.

The report also provides information on key players in this market and their growth strategies and recent developments. This can help the company to assess the competition at global and regional levels in a better manner.

Key insights and market sizing for the different end users of the metabolomics market namely, hospitals, laboratories, academic institutes, biotechnology firms, clinical research laboratories, and other end users.

Country-wise market size and forecast for all the subsegments. Thus, not only the high growth product & service, technology, application, and indication areas; the market size numbers provided in the report will also enable players to identify key geographic markets, and thereby strategize global marketing efforts in order to achieve sustainable revenue growth in the coming years.

It provides key insights on market dynamics, such as drivers, restraints, opportunities, and challenges for this market.

Reasons to Buy the Report

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater market share. Firms purchasing the report could use one or a combination of the below-mentioned five strategies for increasing their market shares.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios offered by top players in the metabolomics market. The report analyzes the market by product & service, application, and indication
  • Product Development/Innovation: Detailed insights on upcoming trends, R&D activities, and new product launches in the metabolomics market
  • Market Development: Comprehensive information on lucrative emerging markets, based on product & service, application, indication, and region
  • Market Diversification: Exhaustive information about new products, growing regions, recent developments, and investments in the metabolomics market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, products, distribution networks, and manufacturing capabilities of leading players in the metabolomics market
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Bruker Corporation
  • Danaher Corporation
  • Leco Corporation
  • Metabolon, Inc.
  • Shimadzu Corporation
  • Waters Corporation
  • MORE

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Research Approach
2.1.1 Secondary Research
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Research
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Market Share Estimation
2.5 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 Metabolomics Market Overview
4.2 Asia-Pacific: Metabolomics Separation Tools Market, By Type
4.3 Geographic Snapshot: Metabolomics Market
4.4 Geographic Mix: Metabolomics Market
4.5 Metabolomics Market: Developing vs Developed Markets

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Market Drivers
5.2.1.1 Availability of Government and Private Funding
5.2.1.2 Increasing Pharmaceutical and Biotech R&D Expenditure
5.2.1.3 Technological Advancements
5.2.1.4 Growing Demand for Personalized Medicine
5.2.1.5 Increasing Use of Metabolomics in Toxicology Testing
5.2.2 Key Market Restraints
5.2.2.1 Issues Related to Data Examination and Processing
5.2.2.2 High Cost of Tools and Instruments
5.2.3 Key Market Opportunities
5.2.3.1 Biomarker Development
5.2.3.2 Rapid Growth Opportunities in Emerging Markets
5.2.4 Key Challenges
5.2.4.1 Complexity and Diversity of Biological Samples
5.2.4.2 Dearth of Skilled Researchers

6 Industry Insights
6.1 Introduction
6.2 Industry Trends
6.2.1 Increasing Adoption of Hyphenated Technologies
6.2.2 Tie-Ups Between Instrument Manufacturers and Research Laboratories/Academic Institutions
6.3 Regulatory Analysis

7 Technology Investment Potential
7.1 Introduction
7.2 Investment Client Networks
7.3 Funding Bodies/Initiatives (2012-2016)
7.4 Analysis of Potential Areas for Technology Investment Using Strategic Evaluation
7.4.1 Parameters Considered for Emerging Opportunity Evaluation
7.4.1.1 Level of Attractiveness
7.4.1.2 Probability of Success
7.4.2 Opportunity Strategic Evaluation Analysis
7.4.3 Description of Opportunities
7.4.3.1 Viable (Quadrant 1) - Biomarker Discovery and Lead Optimization in Drug Discovery
7.4.3.1.1 Biomarker Discovery
7.4.3.1.2 Lead Optimization in Drug Discovery
7.4.3.1.3 Toxicity Testing
7.4.3.2 Promising (Quadrant 2) - Companion Diagnostics for Personalized Medicine and Nutrigenomics
7.4.3.2.1 Companion Diagnostics for Personalized Medicine
7.4.3.2.2 Nutrigenomics
7.4.3.2.3 Agriculture
7.4.3.3 Challenging (Quadrant 3) - Environmental Metabolomics
7.4.3.3.1 Environmental Metabolomics
7.4.3.3.2 Functional Genomics

8 Global Metabolomics Market, By Product and Service
8.1 Introduction
8.2 Metabolomics Instruments
8.2.1 Separation Tools
8.2.1.1 High-Performance Liquid Chromatography
8.2.1.2 Gas Chromatography
8.2.1.3 Ultra-Performance Liquid Chromatography
8.2.1.4 Capillary Electrophoresis
8.2.2 Detection Tools
8.2.2.1 Mass Spectrometry
8.2.2.2 Nuclear Magnetic Resonance Spectroscopy
8.2.2.3 Surface-Based Mass Analysis
8.3 Metabolomics Bioinformatics Tools and Services
8.3.1 Bioinformatics Tools & Databases
8.3.2 Bioinformatics Services

9 Global Metabolomics Market, By Application
9.1 Introduction
9.2 Biomarker Discovery
9.3 Drug Discovery
9.4 Toxicology Testing
9.5 Nutrigenomics
9.6 Functional Genomics
9.7 Personalized Medicine
9.8 Other Applications

10 Global Metabolomics Market, By Indication
10.1 Introduction
10.2 Cancer
10.3 Cardiovascular Disorders
10.4 Neurological Disorders
10.5 Inborn Errors of Metabolism
10.6 Other Indications

11 Global Metabolomics Market, By Region
11.1 Introduction
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 U.K.
11.3.3 France
11.3.4 Italy
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Rest of APAC
11.5 Latin America
11.5.1 Brazil
11.5.2 Mexico
11.5.3 Rest of Latin America
11.6 Middle East and Africa

12 Competitive Landscape
12.1 Overview
12.2 Product Portfolio Analysis
12.3 Market Share Analysis
12.4 Competitive Situations and Trends
12.4.1 Product Launches and Enhancements
12.4.2 Partnerships, Agreements, Collaborations, and Alliances
12.4.3 Expansions
12.4.4 Acquisitions and Divestitures

13 Company Profiles
13.1 Introduction
13.2 Thermo Fisher Scientific Inc.
13.2.1 Business Overview
13.2.2 Products & Services Offered
13.2.3 Recent Developments
13.2.4 MnM View
13.3 Agilent Technologies, Inc.
13.3.1 Business Overview
13.3.2 Products & Services Offered
13.3.3 Recent Developments
13.3.4 MnM View
13.4 Waters Corporation
13.4.1 Business Overview
13.4.2 Products Offered
13.4.3 Recent Developments
13.4.4 MnM View
13.5 Danaher Corporation
13.5.1 Business Overview
13.5.2 Products Offered
13.5.3 Recent Developments
13.5.4 MnM View
13.6 Shimadzu Corporation
13.6.1 Business Overview
13.6.2 Products Offered
13.6.3 Recent Developments
13.6.4 MnM View
13.7 Biocrates Life Sciences AG
13.7.1 Business Overview
13.7.2 Products Offered
13.7.3 Recent Developments
13.8 Bio-Rad Laboratories, Inc.
13.8.1 Business Overview
13.8.2 Products Offered
13.8.3 Recent Developments
13.9 Bruker Corporation
13.9.1 Business Overview
13.9.2 Products & Services Offered
13.9.3 Recent Developments
13.10 Human Metabolome Technologies, Inc.
13.10.1 Business Overview
13.10.2 Products Offered
13.10.3 Recent Developments
13.11 Leco Corporation
13.11.1 Business Overview
13.11.2 Products Offered
13.11.3 Recent Developments
13.12 Metabolon, Inc.
13.12.1 Business Overview
13.12.2 Products Offered
13.12.3 Recent Developments

14 Appendix
14.1 Insights of Industry Experts
14.2 Discussion Guide
14.3 Other Developments

List of Tables

Table 1 Global Metabolomics Market Snapshot
Table 2 Availability of Government and Private Funding to Drive the Market Growth
Table 3 Issues Related to Data Examination and Processing to Restrain Market Growth
Table 4 Biomarker Development to Offer Significant Opportunities for Market Growth
Table 5 Dearth of Skilled Researchers is A Major Challenge in the Market
Table 6 Regulatory Standard/Approval Required for Metabolomics Products, By Country/Region
Table 7 Global Metabolomics Market Size, By Product & Service, 2014-2021 (USD Million)
Table 8 Global Metabolomics Instruments Market Size, By Type, 2014-2021 (USD Million)
Table 9 Global Metabolomics Instruments Market Size, By Country, 2014-2021 (USD Million)
Table 10 Global Metabolomics Separation Tools Market Size, By Type, 2014-2021 (USD Million)
Table 11 Global Metabolomics Separation Tools Market Size, By Country, 2014-2021 (USD Million)
Table 12 Global High-Performance Liquid Chromatography Market Size, By Country, 2014-2021 (USD Million)
Table 13 Global Gas Chromatography Size, By Country, 2014-2021 (USD Million)
Table 14 Global Ultra-Performance Liquid Chromatography Market Size, By Country, 2014-2021 (USD Million)
Table 15 Global Capillary Electrophoresis Market Size, By Country, 2014-2021 (USD Million)
Table 16 Global Metabolomics Detection Tools Market Size, By Type, 2014-2021 (USD Million)
Table 17 Global Metabolomics Detection Tools Market Size, By Country, 2014-2021 (USD Million)
Table 18 Global Mass Spectrometry Market Size, By Country, 2014-2021 (USD Million)
Table 19 Global Nuclear Magnetic Resonance Spectroscopy Market Size, By Country, 2014-2021 (USD Million)
Table 20 Global Surface-Based Mass Analysis Market Size, By Country, 2014-2021 (USD Million)
Table 21 Global Metabolomics Bioinformatics Tools and Services Market Size, By Type, 2014-2021 (USD Million)
Table 22 Global Metabolomics Bioinformatics Tools and Services Market Size, By Country, 2014-2021 (USD Million)
Table 23 Global Bioinformatics Tools & Databases Market Size, By Country, 2014-2021 (USD Million)
Table 24 Global Bioinformatics Services Market Size, By Country, 2014-2021 (USD Million)
Table 25 Global Metabolomics Market Size, By Application, 2014-2021 (USD Million)
Table 26 Global Metabolomics Market Size for Biomarker Discovery Applications, By Country, 2014-2021 (USD Million)
Table 27 Global Metabolomics Market Size for Drug Discovery Applications, By Country, 2014-2021 (USD Million)
Table 28 Global Metabolomics Market Size for Toxicology Testing Applications, By Country, 2014-2021 (USD Million)
Table 29 Global Metabolomics Market Size for Nutrigenomic Applications, By Country, 2014-2021 (USD Million)
Table 30 Global Metabolomics Market Size for Functional Genomic Applications, By Country, 2014-2021 (USD Million)
Table 31 Global Metabolomics Market Size for Personalized Medicine Applications, By Country, 2014-2021 (USD Million)
Table 32 Global Metabolomics Market Size for Other Applications, By Country, 2014-2021 (USD Million)
Table 33 Global Metabolomics Market Size, By Indication, 2014-2021 (USD Million)
Table 34 Global Metabolomics Market Size for Cancer, By Country, 2014-2021 (USD Million)
Table 35 Global Metabolomics Market Size for Cardiovascular Disorders, By Country, 2014-2021 (USD Million)
Table 36 Global Metabolomics Market Size for Neurological Disorders, By Country, 2014-2021 (USD Million)
Table 37 Global Metabolomics Market Size for Inborn Errors of Metabolism, By Country, 2014-2021 (USD Million)
Table 38 Global Metabolomics Market Size for Other Indications, By Country, 2014-2021 (USD Million)
Table 39 Global Metabolomics Market Size, By Region, 2014-2021 (USD Million)
Table 40 North America: Metabolomics Market Size, By Country, 2014-2021 (USD Million)
Table 41 North America: Metabolomics Market Size, By Product & Service, 2014-2021 (USD Million)
Table 42 North America: Metabolomics Instruments Market Size, By Type, 2014-2021 (USD Million)
Table 43 North America: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014-2021 (USD Million)
Table 44 North America: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014-2021 (USD Million)
Table 45 North America: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2014-2021 (USD Million)
Table 46 North America: Metabolomics Market Size, By Application, 2014-2021 (USD Million)
Table 47 North America: Metabolomics Market Size, By Indication, 2014-2021 (USD Million)
Table 48 U.S.: Metabolomics Market Size, By Product & Service, 2014-2021 (USD Million)
Table 49 U.S.: Metabolomics Instruments Market Size, By Type, 2014-2021 (USD Million)
Table 50 U.S.: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014-2021 (USD Million)
Table 51 U.S.: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014-2021 (USD Million)
Table 52 U.S.: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2014-2021 (USD Million)
Table 53 U.S.: Metabolomics Market Size, By Application, 2014-2021 (USD Million)
Table 54 U.S.: Metabolomics Market Size, By Indication, 2014-2021 (USD Million)
Table 55 Canada: Metabolomics Market Size, By Product & Service, 2014-2021 (USD Million)
Table 56 Canada: Metabolomics Instruments Market Size, By Type, 2014-2021 (USD Million)
Table 57 Canada: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014-2021 (USD Million)
Table 58 Canada: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014-2021 (USD Million)
Table 59 Canada: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2014-2021 (USD Million)
Table 60 Canada: Metabolomics Market Size, By Application, 2014-2021 (USD Million)
Table 61 Canada: Metabolomics Market Size, By Indication, 2014-2021 (USD Million)
Table 62 Europe: Metabolomics Market Size, By Country, 2014-2021 (USD Million)
Table 63 Europe: Metabolomics Market Size, By Product & Service, 2014-2021 (USD Million)
Table 64 Europe: Metabolomics Instruments Market Size, By Type, 2014-2021 (USD Million)
Table 65 Europe: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014-2021 (USD Million)
Table 66 Europe: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014-2021 (USD Million)
Table 67 Europe: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2014-2021 (USD Million)
Table 68 Europe: Market Size, By Application, 2014-2021 (USD Million)
Table 69 Europe: Metabolomics Market Size, By Indication, 2014-2021 (USD Million)
Table 70 Germany: Metabolomics Market Size, By Product & Service, 2014-2021 (USD Million)
Table 71 Germany: Metabolomics Instruments Market Size, By Type, 2014-2021 (USD Million)
Table 72 Germany: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014-2021 (USD Million)
Table 73 Germany: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014-2021 (USD Million)
Table 74 Germany: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2014-2021 (USD Million)
Table 75 Germany: Metabolomics Market Size, By Application, 2014-2021 (USD Million)
Table 76 Germany: Metabolomics Market Size, By Indication, 2014-2021 (USD Million)
Table 77 U.K.: Market Size, By Product & Service, 2014-2021 (USD Million)
Table 78 U.K.: Metabolomics Instruments Market Size, By Type, 2014-2021 (USD Million)
Table 79 U.K.: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014-2021 (USD Million)
Table 80 U.K.: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014-2021 (USD Million)
Table 81 U.K.: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2014-2021 (USD Million)
Table 82 U.K.: Metabolomics Market Size, By Application, 2014-2021 (USD Million)
Table 83 U.K.: Metabolomics Market Size, By Indication, 2014-2021 (USD Million)
Table 84 France: Market Size, By Product & Service, 2014-2021 (USD Million)
Table 85 France: Metabolomics Instruments Market Size, By Type, 2014-2021 (USD Million)
Table 86 France: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014-2021 (USD Million)
Table 87 France: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014-2021 (USD Million)
Table 88 France: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2014-2021 (USD Million)
Table 89 France: Metabolomics Market Size, By Application, 2014-2021 (USD Million)
Table 90 France: Metabolomics Market Size, By Indication, 2014-2021 (USD Million)
Table 91 Italy: Metabolomics Market Size, By Product & Service, 2014-2021 (USD Million)
Table 92 Italy: Metabolomics Instruments Market Size, By Type, 2014-2021 (USD Million)
Table 93 Italy: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014-2021 (USD Million)
Table 94 Italy: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014-2021 (USD Million)
Table 95 Italy: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2014-2021 (USD Million)
Table 96 Italy: Market Size, By Application, 2014-2021 (USD Million)
Table 97 Italy: Metabolomics Market Size, By Indication, 2014-2021 (USD Million)
Table 98 Spain: Metabolomics Market Size, By Product & Service, 2014-2021 (USD Million)
Table 99 Spain: Metabolomics Instruments Market Size, By Type, 2014-2021 (USD Million)
Table 100 Spain: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014-2021 (USD Million)
Table 101 Spain: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014-2021 (USD Million)
Table 102 Spain: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2014-2021 (USD Million)
Table 103 Spain: Metabolomics Market Size, By Application, 2014-2021 (USD Million)
Table 104 Spain: Metabolomics Market Size, By Indication, 2014-2021 (USD Million)
Table 105 Rest of Europe: Metabolomics Market Size, By Product & Service, 2014-2021 (USD Million)
Table 106 RoE: Metabolomics Instruments Market Size, By Type, 2014-2021 (USD Million)
Table 107 RoE: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014-2021 (USD Million)
Table 108 RoE: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014-2021 (USD Million)
Table 109 RoE: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2014-2021 (USD Million)
Table 110 RoE: Metabolomics Market Size, By Application, 2014-2021 (USD Million)
Table 111 RoE: Metabolomics Market Size, By Indication, 2014-2021 (USD Million)
Table 112 Asia-Pacific: Market Size, By Country, 2014-2021 (USD Million)
Table 113 Asia-Pacific: Metabolomics Market Size, By Product & Service, 2014-2021 (USD Million)
Table 114 Asia-Pacific: Metabolomics Instruments Market Size, By Type, 2014-2021 (USD Million)
Table 115 Asia-Pacific: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014-2021 (USD Million)
Table 116 Asia-Pacific: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014-2021 (USD Million)
Table 117 Asia-Pacific: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2014-2021 (USD Million)
Table 118 Asia-Pacific: Metabolomics Market Size, By Application, 2014-2021 (USD Million)
Table 119 Asia-Pacific: Metabolomics Market Size, By Indication, 2014-2021 (USD Million)
Table 120 Japan: Metabolomics Market Size, By Product & Service, 2014-2021 (USD Million)
Table 121 Japan: Metabolomics Instruments Market Size, By Type, 2014-2021 (USD Million)
Table 122 Japan: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014-2021 (USD Million)
Table 123 Japan: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014-2021 (USD Million)
Table 124 Japan: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2014-2021 (USD Million)
Table 125 Japan: Metabolomics Market Size, By Application, 2014-2021 (USD Million)
Table 126 Japan: Metabolomics Market Size, By Indication, 2014-2021 (USD Million)
Table 127 China: Metabolomics Market Size, By Product & Service, 2014-2021 (USD Million)
Table 128 China: Metabolomics Instruments Market Size, By Type, 2014-2021 (USD Million)
Table 129 China: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014-2021 (USD Million)
Table 130 China: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014-2021 (USD Million)
Table 131 China: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2014-2021 (USD Million)
Table 132 China: Metabolomics Market Size, By Application, 2014-2021 (USD Million)
Table 133 China: Metabolomics Market Size, By Indication, 2014-2021 (USD Million)
Table 134 India: Metabolomics Market Size, By Product & Service, 2014-2021 (USD Million)
Table 135 India: Metabolomics Instruments Market Size, By Type, 2014-2021 (USD Million)
Table 136 India: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014-2021 (USD Million)
Table 137 India: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014-2021 (USD Million)
Table 138 India: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2014-2021 (USD Million)
Table 139 India: Metabolomics Market Size, By Application, 2014-2021 (USD Million)
Table 140 India: Metabolomics Market Size, By Indication, 2014-2021 (USD Million)
Table 141 RoAPAC: Metabolomics Market Size, By Product & Service, 2014-2021 (USD Million)
Table 142 RoAPAC: Metabolomics Instruments Market Size, By Type, 2014-2021 (USD Million)
Table 143 RoAPAC: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014-2021 (USD Million)
Table 144 RoAPAC: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014-2021 (USD Million)
Table 145 RoAPAC: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2014-2021 (USD Million)
Table 146 RoAPAC: Metabolomics Market Size, By Application, 2014-2021 (USD Million)
Table 147 RoAPAC: Metabolomics Market Size, By Indication, 2014-2021 (USD Million)
Table 148 Latin America: Metabolomics Market Size, By Country, 2014-2021 (USD Million)
Table 149 Latin America: Metabolomics Market Size, By Product & Service, 2014-2021 (USD Million)
Table 150 Latin America: Metabolomics Instruments Market Size, By Type, 2014-2021 (USD Million)
Table 151 Latin America: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014-2021 (USD Million)
Table 152 Latin America: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014-2021 (USD Million)
Table 153 Latin America: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2014-2021 (USD Million)
Table 154 Latin America: Metabolomics Market Size, By Application, 2014-2021 (USD Million)
Table 155 Latin America: Metabolomics Market Size, By Indication, 2014-2021 (USD Million)
Table 156 Brazil: Metabolomics Market Size, By Product & Service, 2014-2021 (USD Million)
Table 157 Brazil: Metabolomics Instruments Market Size, By Type, 2014-2021 (USD Million)
Table 158 Brazil: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014-2021 (USD Million)
Table 159 Brazil: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014-2021 (USD Million)
Table 160 Brazil: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2014-2021 (USD Million)
Table 161 Brazil: Metabolomics Market Size, By Application, 2014-2021 (USD Million)
Table 162 Brazil: Market Size, By Indication, 2014-2021 (USD Million)
Table 163 Mexico: Metabolomics Market Size, By Product & Service, 2014-2021 (USD Million)
Table 164 Mexico: Metabolomics Instruments Market Size, By Type, 2014-2021 (USD Million)
Table 165 Mexico: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014-2021 (USD Million)
Table 166 Mexico: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014-2021 (USD Million)
Table 167 Mexico: Market Size, By Application, 2014-2021 (USD Million)
Table 168 Mexico: Metabolomics Market Size, By Indication, 2014-2021 (USD Million)
Table 169 RoLA: Metabolomics Market Size, By Product & Service, 2014-2021 (USD Million)
Table 170 RoLA: Metabolomics Instruments Market Size, By Type, 2014-2021 (USD Million)
Table 171 RoLA: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014-2021 (USD Million)
Table 172 RoLA: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014-2021 (USD Million)
Table 173 RoLA: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2014-2021 (USD Million)
Table 174 RoLA: Metabolomics Market Size, By Application, 2014-2021 (USD Million)
Table 175 RoLA: Market Size, By Indication, 2014-2021 (USD Million)
Table 176 Middle East & Africa: Metabolomics Market Size, By Product & Service, 2014-2021 (USD Million)
Table 177 Middle East & Africa: Metabolomics Instruments Market Size, By Type, 2014-2021 (USD Million)
Table 178 Middle East & Africa: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014-2021 (USD Million)
Table 179 Middle East & Africa: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014-2021 (USD Million)
Table 180 Middle East & Africa: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2014-2021 (USD Million)
Table 181 Middle East & Africa: Metabolomics Market Size, By Application, 2014-2021 (USD Million)
Table 182 Middle East & Africa: Metabolomics Market Size, By Indication, 2014-2021 (USD Million)
Table 183 Growth Strategy Matrix (January 2013-November 2016)
Table 184 Product Portfolio Analysis: Metabolomics Market
Table 185 Product Launches and Enhancements, 2013-2016
Table 186 Partnerships, Agreements, Collaborations, and Alliances, 2013-2016
Table 187 Expansions, 2013-2016
Table 188 Acquisitions and Divestitures, 2013-2016

List of Figures

Figure 1 Global Metabolomics Market
Figure 2 Research Design
Figure 3 Bottom-Up Approach
Figure 4 Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Global Metabolomics Market, By Product & Service, 2016 vs 2021 (USD Million)
Figure 7 Global Metabolomics Instruments Market, By Type, 2016 vs 2021 (USD Million)
Figure 8 Global Metabolomics Separation Tools Market, By Type, 2016 vs 2021 (USD Million)
Figure 9 Global Metabolomics Detection Tools Market, By Type, 2016 vs 2021 (USD Million)
Figure 10 Global Metabolomics Market for Bioinformatics Tools and Services, By Type, 2016 vs 2021 (USD Million)
Figure 11 Global Metabolomics Market, By Application, 2016 vs 2021 (USD Million)
Figure 12 Global Metabolomics Market, By Indication, 2016 vs 2021 (USD Million)
Figure 13 Asia-Pacific to Register Highest Growth During the Forecast Period
Figure 14 Availability of Government and Private Funding for Research is Driving Growth of the Metabolomics Market
Figure 15 HPLC Commanded the Largest Share of the Asia-Pacific Metabolomics Separation Tools Market in 2015
Figure 16 U.S. Dominated the Global Metabolomics Market in 2015
Figure 17 Asia-Pacific to Register the Highest CAGR in the Forecast Period
Figure 18 Developing Markets to Register Higher Growth During the Forecast Period
Figure 19 Metabolomics Market: Drivers, Restraints, Opportunities, and Challenges
Figure 20 R&D Expenditure of Top Biotechnology and Pharmaceutical Companies, By Geography, 2012-2014
Figure 21 Global Metabolomics Market- Investment Client Network
Figure 22 Opportunity Strategic Evaluation Analysis of Metabolomics in Various Applications Areas
Figure 23 Metabolomics Instruments Dominated the Market in 2016
Figure 24 Biomarker Discovery to Dominate the Metabolomics Applications Market in 2016
Figure 25 Cancer Indication to Dominate the Market in 2016
Figure 26 Global Metabolomics Market: Geographical Snapshot
Figure 27 North America: Metabolomics Market Snapshot
Figure 28 Europe: Metabolomics Market Snapshot
Figure 29 Asia-Pacific: Metabolomics Market Snapshot
Figure 30 Key Developments in the Metabolomics Market, 2013-2016
Figure 31 Global Metabolomics Market Share Analysis, By Key Player, 2015
Figure 32 Battle for Market Share: Product Launches & Enhancements Was the Key Growth Strategy Adopted By Market Players
Figure 33 Geographic Revenue Mix of the Major Players in the Metabolomics Market
Figure 34 Thermo Fisher Scientific Inc.: Company Snapshot (2015)
Figure 35 Company Snapshot: Agilent Technologies, Inc.: (2015)
Figure 36 Waters Corporation: Company Snapshot (2015)
Figure 37 Danaher Corporation: Company Snapshot (2015)
Figure 38 Shimadzu Corporation: Company Snapshot (2015)
Figure 39 Bio-Rad Laboratories, Inc.: Company Snapshot (2015)
Figure 40 Bruker Corporation: Company Snapshot (2015)
Figure 41 Marketsandmarkets Knowledge Store Snapshot
Figure 42 Marketsandmarkets Knowledge Store: Healthcare Industry Snapshot

Note: Product cover images may vary from those shown
3 of 4

FEATURED COMPANIES

  • Bruker Corporation
  • Danaher Corporation
  • Leco Corporation
  • Metabolon, Inc.
  • Shimadzu Corporation
  • Waters Corporation
  • MORE

The global metabolomics market is estimated to reach USD 2.39 Billion by 2021, at a CAGR of 14.6% during the forecast period. The growing acceptance of metabolomics for personalized medicine, increasing pharmaceutical and biotech R&D expenditure, and continuous technological advancements are some of the factors driving market growth. New range of enhanced technologies for accuracy and precision in metabolomics research and growth in emerging markets due to increasing investments presents significant growth opportunities for players in the market. However, issues related to data examination and processing and high-cost tools and instruments and their maintenance are the major restraining factors for this market.

In this report, the market is segmented on the basis of product & service, application, indication, and region. The research report discusses key market drivers, restraints, opportunities, and challenges in the global market and its submarkets. Based on product & service, the market is segmented into metabolomics instruments and metabolomics bioinformatics tools & services. The metabolomics instruments segment accounted for the largest share of the market in 2015. However, metabolomics bioinformatics tools & services is expected to grow at the highest CAGR during the forecast period. The ability of metabolome analysis software tools for interpreting the results of analytical experiments and understand the potential of metabolomics data generated from analytical tools are expected to drive the growth of this segment.

Based on application, the metabolomics market is segmented into biomarker discovery, drug discovery, nutrigenomics, toxicology testing, personalized medicine, functional genomics, and other applications. The biomarker discovery segment accounted for the largest share of the global metabolomics market in 2015. The large share of the biomarker discovery segment can be attributed to the rising incidence and prevalence of chronic diseases such as CVD, cancer, and diabetes; growing acceptance of cancer diagnostic tests; and scientific progression in discovery technologies.

In this report, the global metabolomics market has been studied at the regional and country levels. In 2015, North America represented the largest regional market, followed by Europe. North America will continue to dominate the market during the forecast period, the Asia-Pacific region is expected to register the highest growth. The growth of this regional segment is driven by the significant economic development in emerging markets, metabolomic technologies playing an integral role in the modern pharmaceutical and healthcare industries, and rising focus of key market players in this region.

The major players in the global metabolomics market are Agilent Technologies, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), Shimadzu Corporation (Japan), Metabolon Inc. (U.S.), LECO Corporation (U.S.), Biocrates Life Sciences AG (Austria), Human Metabolome Technologies, Inc. (Japan), and Waters Corporation (U.S.).

Note: Product cover images may vary from those shown
4 of 4
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Biocrates Life Sciences AG
  • Bruker Corporation
  • Danaher Corporation
  • Human Metabolome Technologies, Inc.
  • Leco Corporation
  • Metabolon, Inc.
  • Shimadzu Corporation
  • Thermo Fisher Scientific Inc.
  • Waters Corporation
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll